ALKM (ALKM) Stock Price & Analysis
ALKM (ALKM) rose 0.00% to USD 0 as of June 10, 2026 at 07:25 UTC, according to Nexqual real-time market data.
ALKM last closed at USD 0; the session ranged USD 0–0 on volume of 475,000 shares. Market capitalization is $864,638, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 07:25 UTC.
Key Statistics (as of June 10, 2026 at 07:25 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 475,000 shares |
| Market Cap | $864,638 |
| Exchange | PNK |
Technical Analysis (ALKM)
Nexqual's technical model rates ALKM "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:25 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ALKM)
Wall Street analysts rate ALKM "None", per Nexqual as of June 10, 2026 at 07:25 UTC.
| Consensus Rating | None |
|---|
Earnings (ALKM)
Source: Nexqual, June 10, 2026 at 07:25 UTC.
Financials & Fundamentals (ALKM)
| Total Revenue | $185,270 |
|---|---|
| Revenue Growth (YoY) | -86.30% |
| Gross Margin | -25.61% |
| Operating Margin | -1496.23% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Debt | $1.05M |
| Free Cash Flow | $278,297 |
Source: Nexqual, June 10, 2026 at 07:25 UTC.
Financial Health Score (ALKM)
Nexqual rates ALKM's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:25 UTC.
| Growth | Critical — Revenue -86% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — No data |
| Cash Flow | Strong — FCF $278K, 150% margin |
| Efficiency | Mixed — No data |
Ownership (ALKM)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 8.65B |
| Float | 5.50B |
Source: Nexqual, June 10, 2026 at 07:25 UTC.
Leadership (ALKM)
ALKM is led by Robert K. Eakle (age 52), CEO, President & Director, per Nexqual as of June 10, 2026 at 07:25 UTC.
| CEO, President & Director | Robert K. Eakle (age 52) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PURA | Puration Inc. | USD 0 | ▲ 0% |
| USMJ | NORTH AMERICAN CANNABIS HLDGS I | USD 0 | ▲ 0% |
| NOUV | Nouveau Life Pharmaceuticals, I | USD 0 | ▲ 0% |
| PAOG | PAO Group, Inc. | USD 0 | ▲ 0% |
| KALY | KALI INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:25 UTC. This page is informational and not investment advice.